“…The selected study characteristics are listed in Table 1. Of all the studies, 72.2% investigated both GSTM1 and GSTT1 polymorphisms [10][11][12][13][17][18][19][20][22][23][24][25]27], 17.8% concerned only GSTM1 polymorphism [14][15][16]21,26]; eight were carried out in Caucasian subjects [10,12,14,18,[20][21][22][23], 10 in Asian populations [11,13,[15][16][17]19,[24][25][26][27]; and hospital subjects were used as controls in 15 studies whereas general population were controls in 3 studies [20,21,25]; as well as 11 selected cases with mixed revised American Fertility Society (rAFS) stages, 7 with complete advanced rAFS stages (rAFS III/IV) [13,17,19,22,[25][26][27].…”